Zev A. Wainberg
Department of Medicine
Division of Hematology/Oncology
Geffen School of Medicine at UCLA
Los Angeles
USA
Name/email consistency: high
- Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo. Wainberg, Z.A., Anghel, A., Desai, A.J., Ayala, R., Luo, T., Safran, B., Fejzo, M.S., Hecht, J.R., Slamon, D.J., Finn, R.S. Clin. Cancer Res. (2010)
- Panitumumab in colorectal cancer. Wainberg, Z.A., Hecht, J.R. Expert. Rev. Anticancer. Ther (2007)